Alberta Investment Management Corp bought a new position in shares of Amrize Ltd (NYSE:AMRZ – Free Report) during the 4th quarter, Holdings Channel reports. The institutional investor bought 241,100 shares of the company’s stock, valued at approximately $13,039,000.
A number of other institutional investors have also recently bought and sold shares of the stock. Vanguard Group Inc. grew its holdings in shares of Amrize by 5.6% during the fourth quarter. Vanguard Group Inc. now owns 31,770,926 shares of the company’s stock worth $1,722,500,000 after buying an additional 1,676,843 shares in the last quarter. Norges Bank acquired a new stake in Amrize in the 4th quarter valued at approximately $929,333,000. Wellington Management Group LLP raised its position in Amrize by 48.8% in the 3rd quarter. Wellington Management Group LLP now owns 11,622,024 shares of the company’s stock valued at $561,018,000 after buying an additional 3,809,133 shares during the last quarter. Harris Associates L P bought a new stake in Amrize in the 4th quarter valued at approximately $615,406,000. Finally, Zurcher Kantonalbank Zurich Cantonalbank lifted its stake in Amrize by 1.6% in the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 9,674,921 shares of the company’s stock valued at $532,076,000 after acquiring an additional 156,903 shares in the last quarter.
Insiders Place Their Bets
In other Amrize news, insider Nollaig Forrest purchased 2,000 shares of the company’s stock in a transaction that occurred on Friday, May 22nd. The shares were acquired at an average price of $50.25 per share, for a total transaction of $100,500.00. Following the purchase, the insider owned 20,139 shares in the company, valued at approximately $1,011,984.75. The trade was a 11.03% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is accessible through this link. Also, CTO Roald Brouwer bought 1,500 shares of Amrize stock in a transaction that occurred on Thursday, May 21st. The shares were bought at an average cost of $49.84 per share, with a total value of $74,760.00. Following the acquisition, the chief technology officer directly owned 19,757 shares in the company, valued at $984,688.88. This trade represents a 8.22% increase in their position. The disclosure for this purchase is available in the SEC filing. Insiders bought 54,920 shares of company stock worth $2,717,429 in the last three months. 0.54% of the stock is owned by corporate insiders.
Amrize Stock Performance
Amrize (NYSE:AMRZ – Get Free Report) last issued its earnings results on Wednesday, April 29th. The company reported ($0.16) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.14) by ($0.02). Amrize had a net margin of 9.70% and a return on equity of 9.84%. The firm had revenue of $2.18 billion during the quarter. The company’s revenue was up 4.7% compared to the same quarter last year. As a group, equities analysts forecast that Amrize Ltd will post 2.76 earnings per share for the current year.
Amrize Cuts Dividend
The firm also recently declared a dividend, which was paid on Wednesday, May 20th. Shareholders of record on Tuesday, May 12th were given a dividend of $0.11 per share. The ex-dividend date of this dividend was Tuesday, May 12th. Amrize’s payout ratio is 21.05%.
Analysts Set New Price Targets
AMRZ has been the subject of several recent research reports. Wells Fargo & Company reduced their target price on shares of Amrize from $66.00 to $65.00 and set an “overweight” rating for the company in a report on Wednesday, April 15th. Berenberg Bank set a $70.00 price target on shares of Amrize in a research note on Thursday, February 19th. Stephens reissued an “overweight” rating and set a $65.00 price target on shares of Amrize in a research report on Monday, May 18th. Oppenheimer set a $68.00 price objective on shares of Amrize in a research note on Friday, May 1st. Finally, JPMorgan Chase & Co. raised their price objective on Amrize from $60.00 to $70.00 and gave the company an “overweight” rating in a report on Thursday, March 5th. One analyst has rated the stock with a Strong Buy rating, ten have given a Buy rating and six have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $64.86.
Get Our Latest Research Report on AMRZ
Amrize Company Profile
Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.
Read More
- Five stocks we like better than Amrize
- Credo Technologies Accelerates AI—Its Stock Price Will Follow
- Qualcomm Goes All-In: The $10B Bet to Crush NVIDIA
- Jabil Just Gave Investors a Stronger Reason to Buy the Dip
- CarMax In Reverse? Why You Should Buy Now Before the Big Catalysts Emerge
Want to see what other hedge funds are holding AMRZ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amrize Ltd (NYSE:AMRZ – Free Report).
Receive News & Ratings for Amrize Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amrize and related companies with MarketBeat.com's FREE daily email newsletter.
